A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent.
A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals.
A naturally occurring metabolite of HISTIDINE that has antioxidant properties.
Toxic compounds produced by FUNGI.
Infections with fungi of the genus ASPERGILLUS.
Animals that are generated from breeding two genetically dissimilar strains of the same species.

Exposure of N-acetylglucosamine decreases early in dexamethasone-induced apoptosis in thymocytes, demonstrated by flow cytometry using wheat germ agglutinin and pokeweed mitogen. (1/100)

In the present paper we describe changes in the exposure of oligosaccharides containing N-acetylglucosamine (Glc-NAc) during apoptosis of mouse thymocytes. The structures containing this sugar were probed with fluorescein isothiocyanate-labelled lectins, wheat germ agglutinin and pokeweed mitogen in flow cytometric assays. Both lectins bind to structures containing Glc-NAc. The present report describes experiments in which two different dual-staining techniques were used to simultaneously identify apoptotic cells and measure their lectin exposure. In these experiments, we observed an early and substantial decrease in the exposure of Glc-NAc-containing structures associated with the onset of apoptosis, before or simultaneously with phosphatidylserine exposure. This was followed by an increase in the exposure of Glc-NAc-containing structures after longer incubation times, when a large proportion of cells was demonstrated to have fragmented DNA. These results provide evidence for major changes in the structure of plasma membrane oligosaccharides during apoptosis. The initial decrease may be a by-product of the hydrolysis of glycosphingolipids to yield ceramide for apoptotic signalling or a deliberate process related to the removal of cell adhesion signalling structures, associated with the separation of the apoptotic cell from its neighbours. The later increase in Glc-NAc-containing structures may be the result of the incorporation of internal membranes into the plasma membrane or a deliberate production of prophagocytic signals by a still-functioning Golgi apparatus.  (+info)

Increased cell surface exposure of phosphatidylserine on propidium iodide negative thymocytes undergoing death by necrosis. (2/100)

Phosphatidylserine (PS) exposure on propidium iodide negative cells using FITC labelled annexin-V has been used to quantify apoptosis in vitro and in vivo. Detection of PS within cells undergoing necrosis is also possible if labelled annexin-V specific for PS enters the cell following early membrane damage. Necrotic or late apoptotic cells can be excluded from flow cytometric analysis using propidium iodide which enters and stains cells with compromised membrane integrity. Here we show that thymocytes undergoing death exclusively by necrosis show early exposure of PS prior to loss of membrane integrity. This early exposure of PS occurs in cells treated with agents which both raise intracellular calcium levels and are also capable of interacting with protein thiol groups. We also demonstrate that PS exposure in thymocytes induced to undergo apoptosis by three different agents does not correlate with calcium rises but correlates with and precedes DNA fragmentation.  (+info)

The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. (3/100)

BACKGROUND: The fungal epipolythiodioxopiperazine metabolite gliotoxin has a variety of toxic effects such as suppression of antigen processing, induction of macrophagocytic apoptosis and inhibition of transcription factor NF-kappaB activation. How gliotoxin acts remains poorly understood except that the molecule's characteristic disulfide bridge is important for immunomodulation. As this fungal metabolite stabilizes the NF-kappaB inhibitor IkappaBalpha in the cytoplasm, we decided to investigate its molecular mechanism of action. RESULTS: We show that gliotoxin is an efficient, noncompetitive inhibitor of the chymotrypsin-like activity of the 20S proteasome in vitro. Proteasome inhibition can be reversed by dithiothreitol, which reduces gliotoxin to the dithiol compound. In intact cells, gliotoxin inhibits NF-kappaB induction through inhibition of proteasome-mediated degradation of IkappaBalpha. CONCLUSIONS: Gliotoxin targets catalytic activities of the proteasome efficiently. Inhibition by gliotoxin may be countered by reducing agents, which are able to inactivate the disulfide bridge responsible for the inhibitory capacity of gliotoxin.  (+info)

NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. (4/100)

Tumor necrosis factor (TNF)-alpha is a potent inducer of apoptotic cell death in various tissues, whereas the transcription factor nuclear factor (NF)-kappaB is essential to protect against TNF-alpha-induced apoptosis. Human hepatoma cell lines were used to investigate the effectiveness and specificity of the fungal metabolite gliotoxin in inhibiting TNF-alpha-induced NF-kappaB activation in transformed cells. Gliotoxin-TNF-alpha cotreatment induced massive apoptosis in these otherwise TNF-alpha-resistant cell lines. With the use of the mouse partial hepatectomy model, we were also able to demonstrate in vivo the capacity of gliotoxin to act as inhibitor of NF-kappaB activation. Bromodeoxyuridine staining of liver sections showed that the lack of NF-kappaB activation correlated with 80% reduction of DNA synthesis 48 h after hepatectomy compared with untreated controls. Additionally, animals treated with gliotoxin showed nuclear condensation and DNA laddering of hepatocytes indicative of apoptosis 24 h after hepatectomy. In summary, our results demonstrate that NF-kappaB is essential in defining the fate of liver cells in response to TNF-alpha in vivo and furthermore implicate gliotoxin as a potential new response modifier for TNF-alpha-based therapy.  (+info)

Gliotoxin-induced cytotoxicity proceeds via apoptosis and is mediated by caspases and reactive oxygen species in LLC-PK1 cells. (5/100)

Renal failure associated with aspergillosis is caused by pathogenic fungi. Gliotoxin is a toxic epipolythiodioxopiperazine metabolite produced by the pathogens. The present study investigated the cytotoxicity and underlying mechanisms induced by gliotoxin in LLC-PK1 cells, a porcine renal proximal tubular cell line. Gliotoxin at 100 ng/ml did not show a cytotoxic effect, but unmasked a dose-dependent cell death induced by TNF-alpha. TNF-alpha-induced cell death in the presence of gliotoxin was associated with hypodiploid nuclei and activation of caspase-3-like proteases. Blockade of caspases by boc-aspartyl (OMe)-fluoromethylketone and z-DEVD.fmk inhibited TNF-alpha-induced cell death. As the concentrations of gliotoxin were increased, gliotoxin killed the cells directly in a dose-dependent manner. Further analyses of DNA fragmentation, hypodiploid nuclei, mitochondrial membrane potential, and plasma membrane integrity revealed that cell death proceeded via apoptosis. Gliotoxin-induced apoptosis was associated with dose-dependent and time-dependent activation of caspase-3-like proteases. Boc-aspartyl (OMe)-fluoromethylketone attenuated the killing effect. Gliotoxin also increased the intracellular levels of reactive oxygen species as measured by flow cytometry. N-acetylcysteine, a well-known antioxidant, completely abolished the gliotoxin-induced caspase-3-like activity, cytotoxicity, and reactive oxygen species. In conclusion, (1) gliotoxin at 100 ng/ml unmasks the ability of TNF-alpha-induced apoptosis, and the effect of TNF-alpha is mediated by caspase-3-like proteases; and (2) at higher concentrations gliotoxin itself induces cell death, which is via apoptosis and dependent on caspase-3-like activity and reactive oxygen species.  (+info)

Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. (6/100)

In acute DSS-induced colitis nuclear factor (NF)-kappaB-dependent inflammatory cytokines including IL-1 and tumour necrosis factor-alpha (TNF-alpha) are up-regulated. Here we examined the effects of gliotoxin, a fungal metabolite known to inhibit NF-kappaB activity, on cytokine production by a mouse cell system in vitro and on intestinal inflammation and NF-kappaB activation in vivo. In vitro gliotoxin decreased TNF-alpha gene expression and protein production by RAW-264.7 mouse macrophage-like cells stimulated with lipopolysaccharide. In vivo, gliotoxin treatment of mice was begun on day 3 of 5% DSS application dissolved in the drinking water and continued until day 8. Gliotoxin treatment dose-dependently down-regulated colonic inflammation as assessed histologically and in parallel there was a suppression of colonic TNF-alpha and IL-1alpha mRNA expression on day 8 as analysed by semiquantitative reverse transcriptase-polymerase chain reaction (P < 0.01). Furthermore, colonic NF-kappaB DNA-binding activity was increased in DSS-induced colitis and was suppressed by gliotoxin. These results demonstrate the essential role of NF-kappaB in DSS-induced colitis and indicate a molecular approach to the treatment of intestinal inflammatory disorders.  (+info)

Inactivation of rabbit muscle creatine kinase by reversible formation of an internal disulfide bond induced by the fungal toxin gliotoxin. (7/100)

The biological activity of gliotoxin is dependent on the presence of a strained disulfide bond that can react with accessible cysteine residues on proteins. Rabbit muscle creatine kinase contains 4 cysteines per 42-kDa subunit and is active in solution as a dimer. Only Cys-282 has been identified as essential for activity. Modification of this residue results in loss of activity of the enzyme. Treatment of creatine kinase with gliotoxin resulted in a time-dependent loss of activity abrogated in the presence of reducing agents. Activity was restored when the inactivated enzyme was treated with reducing agents. Inactivation of creatine kinase by gliotoxin was accompanied by the formation of a 37-kDa form of the enzyme. This oxidized form of creatine kinase was rapidly reconverted to the 42-kDa species by the addition of reducing agents concomitant with restoration of activity. A 1:1 mixture of the oxidized and reduced monomer forms of creatine kinase as shown on polyacrylamide gel electrophoresis was equivalent to the activity of the fully reduced form of the enzyme consistent with only one reduced monomer of the dimer necessary for complete activity. Conversion of the second monomeric species of the dimer to the oxidized form by gliotoxin correlated with loss of activity. Our data are consistent with gliotoxin inducing the formation of an internal disulfide bond in creatine kinase by initially binding and possibly activating a cysteine residue on the protein, followed by reaction with a second neighboring thiol. The recently published crystal structure of creatine kinase suggests the disulfide is formed between Cys-282 and Cys-73.  (+info)

Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis. (8/100)

Nerve growth factor (NGF) receptors are expressed in different cell types outside the nervous system, and increasing evidence indicates that NGF can act as a regulatory molecule during inflammatory and immune responses. In this study, we show that triggering of the high-affinity NGF receptor TrkA with agonists protects monocytes from apoptosis induced by gliotoxin or UVB radiation. TrkA stimulation up-regulates the expression of the anti-apoptotic Bcl-2 family members, Bcl-2, Bcl-XL, and Bfl-1. On the other hand, TrkA stimulation does not change the expression of MHC, CD80, CD86, CD40, and CD54 molecules, nor the antigen-presenting function of monocytes. In addition, during in vitro monocyte to dendritic cell differentiation TrkA expression is progressively lost, suggesting that NGF selectively affects monocyte but not dendritic cell survival.  (+info)

Gliotoxin is not typically defined in the context of medical terminology, but it is a specific type of toxin that is produced by certain types of fungi. It's a mycotoxin, which is a toxic compound that is naturally produced by some types of molds (fungi).

Gliotoxin has been studied in the field of medical research due to its potential implications in various disease processes, particularly in relation to immune system function and inflammation. It has been found to have immunosuppressive effects and can inhibit the growth and activity of certain types of immune cells. This has led to interest in its potential role in conditions such as allergies, asthma, and various infectious diseases.

However, it's important to note that gliotoxin is not a term commonly used in medical diagnoses or treatments. Instead, it's a topic of research into possible mechanisms of disease and potential therapeutic targets.

'Aspergillus fumigatus' is a species of fungi that belongs to the genus Aspergillus. It is a ubiquitous mold that is commonly found in decaying organic matter, such as leaf litter, compost, and rotting vegetation. This fungus is also known to be present in indoor environments, including air conditioning systems, dust, and water-damaged buildings.

Aspergillus fumigatus is an opportunistic pathogen, which means that it can cause infections in people with weakened immune systems. It can lead to a range of conditions known as aspergillosis, including allergic reactions, lung infections, and invasive infections that can spread to other parts of the body.

The fungus produces small, airborne spores that can be inhaled into the lungs, where they can cause infection. In healthy individuals, the immune system is usually able to eliminate the spores before they can cause harm. However, in people with weakened immune systems, such as those undergoing chemotherapy or organ transplantation, or those with certain underlying medical conditions like asthma or cystic fibrosis, the fungus can establish an infection.

Infections caused by Aspergillus fumigatus can be difficult to treat, and treatment options may include antifungal medications, surgery, or a combination of both. Prompt diagnosis and treatment are essential for improving outcomes in people with aspergillosis.

Ergothioneine is a naturally occurring antioxidant compound that is found in various foods such as mushrooms, some types of beans, and certain grains. It is also produced by some bacteria that live in the human body. Ergothioneine has been shown to have potential health benefits due to its antioxidant properties, which help protect cells from damage caused by free radicals. Some studies suggest that ergothioneine may have neuroprotective effects and could play a role in preventing neurodegenerative diseases such as Parkinson's and Alzheimer's. However, more research is needed to fully understand the potential health benefits of this compound.

Mycotoxins are toxic secondary metabolites produced by certain types of fungi (molds) that can contaminate food and feed crops, both during growth and storage. These toxins can cause a variety of adverse health effects in humans and animals, ranging from acute poisoning to long-term chronic exposure, which may lead to immune suppression, cancer, and other diseases. Mycotoxin-producing fungi mainly belong to the genera Aspergillus, Penicillium, Fusarium, and Alternaria. Common mycotoxins include aflatoxins, ochratoxins, fumonisins, zearalenone, patulin, and citrinin. The presence of mycotoxins in food and feed is a significant public health concern and requires stringent monitoring and control measures to ensure safety.

Aspergillosis is a medical condition that is caused by the infection of the Aspergillus fungi. This fungus is commonly found in decaying organic matter, such as leaf litter and compost piles, and can also be found in some indoor environments like air conditioning systems and old buildings with water damage.

There are several types of aspergillosis, including:

1. Allergic bronchopulmonary aspergillosis (ABPA): This type of aspergillosis occurs when a person's immune system overreacts to the Aspergillus fungi, causing inflammation in the airways and lungs. ABPA is often seen in people with asthma or cystic fibrosis.
2. Invasive aspergillosis: This is a serious and potentially life-threatening condition that occurs when the Aspergillus fungi invade the bloodstream and spread to other organs, such as the brain, heart, or kidneys. Invasive aspergillosis typically affects people with weakened immune systems, such as those undergoing chemotherapy or organ transplantation.
3. Aspergilloma: Also known as a "fungus ball," an aspergilloma is a growth of the Aspergillus fungi that forms in a preexisting lung cavity, such as one caused by previous lung disease or injury. While an aspergilloma itself is not typically harmful, it can cause symptoms like coughing up blood or chest pain if it grows too large or becomes infected.

Symptoms of aspergillosis can vary depending on the type and severity of the infection. Treatment may include antifungal medications, surgery to remove the fungal growth, or management of underlying conditions that increase the risk of infection.

"Outbred strains" of animals in a medical context refers to populations of animals that are not genetically identical or inbred. These animals are derived from matings between individuals from different genetic backgrounds and are characterized by a high degree of genetic variability. This genetic diversity is maintained through random mating and selection, allowing for a wide range of phenotypic traits to be expressed within the population.

Outbred strains are often used in biomedical research as they provide a more genetically diverse background compared to inbred or genetically modified animal models. This genetic diversity can help to better represent human populations and improve the translatability of research findings to clinical applications. Additionally, outbred animals may be less susceptible to certain experimental artifacts that can arise from the use of highly inbred strains, such as reduced immune function or increased susceptibility to disease.

Examples of commonly used outbred animal models include the Sprague-Dawley rat and the Swiss Webster mouse. These animals are widely used in a variety of research areas, including toxicology, pharmacology, behavioral studies, and basic biomedical research.

Gliotoxin acts by blocking thiol residues in the cell membrane. Gliotoxin also activates a member of the Bcl-2 family called ... Gliotoxin is also believed to interfere with T-cell activation. Additionally, gliotoxin acts as an inhibitor of farnesyl ... Acute symptoms of gliotoxin start rapidly after ingestion. Understanding the mechanisms behind the toxicity of gliotoxin can ... The chemical structure of gliotoxin was resolved in 1958 by Bell et al. by treatment of gliotoxin on alkaline alumina. Bell and ...
Pesticide properties for Gliotoxin, including approvals, environmental fate, eco-toxicity and human health issues ...
The biosynthesis of gliotoxin, a virulence factor of the human pathogenic fungus Aspergillus fumigatus, involves attachment of ... The latter results suggest a reaction mechanism in which the two scissile peptide bonds of one gliotoxin precursor molecule are ...
gliotoxin biosynthetic process (GO:2001310) is_a gliotoxin metabolic process gliotoxin catabolic process (GO:2001309) is_a ... Parents of gliotoxin metabolic process (GO:2001308) subject. relation. object. gliotoxin metabolic process is_a organic cyclic ... gliotoxin metabolic process is_a heterocycle metabolic process (GO:0046483) gliotoxin metabolic process is_a peptide metabolic ... gliotoxin metabolic process is_a mycotoxin metabolic process (GO:0043385) gliotoxin metabolic process is_a sulfur compound ...
down regulation of gliotoxin anabolism, down regulation of gliotoxin biosynthesis, down regulation of gliotoxin biosynthetic ... gliotoxin biosynthetic process (GO:2001310) negative regulation of gliotoxin biosynthetic process is_a negative regulation of ... regulation of gliotoxin biosynthetic process (GO:1900689) negative regulation of gliotoxin biosynthetic process RO:0002212 ... down regulation of gliotoxin synthesis, down-regulation of gliotoxin anabolism, down-regulation of gliotoxin biosynthesis, down ...
ProteomicGliotoxinICATIsotope coded affinity tagSchool: School of Biological Sciences060104 Cell Metabolism060109 Proteomics ... Cells exposed to gliotoxin and control cells were then labeled with ICAT reagents and analysed by offline reversed phase liquid ... The aim of this study was to use HL-60 cells treated with gliotoxin, a fungal metabolite with a reactive disulfide bridge, as a ... Cellular effects of gliotoxin: Evaluation of a proteomic, isotope-based method to detect reactive cysteines. ...
Return to Article Details Cytotoxic effect of Gliotoxin from Candida spp. isolated from clinical sources against cancer and ...
Towards understanding the gliotoxin detoxification mechanism: in vivo thiomethylation protects yeast from gliotoxin ... Towards understanding the gliotoxin detoxification mechanism: in vivo thiomethylation protects yeast from gliotoxin ... Towards understanding the gliotoxin detoxification mechanism: in vivo thiomethylation protects yeast from gliotoxin ... Gliotoxin (GT) is a mycotoxin produced by some species of asco-mycete fungi including the opportunistic human pathogen ...
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from ATCC.. While ATCC uses reasonable efforts to include accurate and up-to-date information on this product sheet, ATCC makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. ATCC does not warrant that such information has been confirmed to be accurate or complete and the customer bears the sole responsibility of confirming the accuracy and completeness of any such information.. This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the ATCC product including without limitation taking all appropriate safety and handling precautions to ...
gliotoxin catabolic process. 0. glutathione derivative catabolic process +. 0. glycosinolate catabolic process +. 0. ...
Gliotoxin. Ochratoxin. Signs and Symptoms. *Excess fatigue. *Excess aches and pain. *Headache ...
... such as gliotoxin. Mutants also display increased sensitivity to cell wall and oxidative stress agents. Overall, these data ...
BRENDA - The Comprehensive Enzyme Information System
Gliotoxin, produced by many fungi.. Vitamin D Deficiency and Biochemical Balance. Random supplementation with high doses of ...
Gliotoxin is Antibacterial to Drug-resistant Piscine Pathogens Feng H, Liu S, Su M, Kim EL, Hong J, Jung JH ... By activity-guided fractionation, gliotoxin was isolated as an antibacterial metabolite of the fungus Penicillium decumbens ...
Things like the trichothecenes and gliotoxin and ochratoxin A and things like that. And, of course, so many of us are living in ...
Doesnt get Zearalenone, doesnt get Gliotoxin from the research we found. I like bentonite clay, it works for most of the mold ...
Gliotoxin as putative virulence factor and immunotherapeutic target in a cell culture model of cerebral aspergillosis.. Speth C ...
Compaore et al.35 and Agastian et al.36 reported that A. fumigatus produces fumagillin and gliotoxin optimally in a synthetic ...
Cellular targeting of the apoptosis-inducing compound Gliotoxin to fibrotic rat livers. The Journal of Pharmacology and ...
S. boulardii may help negate gliotoxin, a nasty toxin that candida and mold make to suppress the immune system. (4) ...
S. boulardii may help negate gliotoxin, a nasty toxin that candida and mold make to suppress the immune system. (4) ...
Candida can produce Gliotoxin, which can be a very dangerous toxin effecting the immune system. It can out regulate pathways as ... Gliotoxin can also affect the circulation and clot the blood, predisposing those who have it to strokes. They can infiltrate ... Candida also produces another chemical called Interleukin, in the presence of Gliotoxin. The presence of the two can create ...
Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers. Hagens, W. I., Beljaars, L., Mann, D. A ...
What is a Gliotoxin?. A gliotoxin is a toxic chemical compound produced by Aspergillus that inhibits the communication pathways ... have led to a huge increase in health issues caused by mycotoxin poisoning via Aspergillus metabolites such as gliotoxin. ...
gliotoxin metabolic process + glutamate catabolic process to 4-hydroxybutyrate glycyrrhetinate metabolic process + ...
2010) Self-Protection against Gliotoxin-A Component of the Gliotoxin Biosynthetic Cluster, GliT, Completely Protects ... 2011) The Role of Glutathione S-Transferase GliG in Gliotoxin Biosynthesis in Aspergillus fumigatus. Chemistry and Biology, ... Aspergillus fumigatus Against Exogenous Gliotoxin. PLoS Pathogens, 6 . [DOI] [Full-Text]. 2008. Stephens J.C., Butler R.N., ...
Polymer functionalized single walled carbon nanotubes mediated drug delivery of gliotoxin in cancer cells. J. Biomed. ...

No FAQ available that match "gliotoxin"

No images available that match "gliotoxin"